FMC
34
-2
ZTS
49
-5
ITW
67
3
HSY
40
3
TXT
55
2
ISRG
73
2
HES
65
2
KLAC
57
4
AVY
57
2
XRX
44
2
SO
62
-2
BXP
55
-4
TXN
45
2
PPG
64
3
EL
30
-4
SRE
57
8
APA
30
3
NWSA
80
18
F
48
-3
AVGO
22
4
FMC
34
-2
ZTS
49
-5
ITW
67
3
HSY
40
3
TXT
55
2
ISRG
73
2
HES
65
2
KLAC
57
4
AVY
57
2
XRX
44
2
SO
62
-2
BXP
55
-4
TXN
45
2
PPG
64
3
EL
30
-4
SRE
57
8
APA
30
3
NWSA
80
18
F
48
-3
AVGO
22
4
Financhill
Back

Recursion Pharmaceuticals Vs. Revance Therapeutics Industry Stock Comparison

Buy
72

RXRX
Recursion Pharmaceuticals

Last Price:
7.09
Seasonality Move:
18.05%
Sell
12

RVNC
Revance Therapeutics

Last Price:
3.64
Seasonality Move:
4.87%
Buy
72
Recursion Pharmaceuticals (RXRX) is a Buy

Is Recursion Pharmaceuticals a Buy, Sell or Hold?

  • The current Recursion Pharmaceuticals [RXRX] share price is $7.07. The Score for RXRX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • RXRX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
12
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

  • The current Revance Therapeutics [RVNC] share price is $3.61. The Score for RVNC is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • RVNC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

RXRX Stock Price Chart

What is Recursion Pharmaceuticals's stock price today?

  • The Recursion Pharmaceuticals share price today is $7.07
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

  • The Revance Therapeutics share price today is $3.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing selling pressure, which indicates risk of future bearish movement.

RXRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 57.65 Buy
Chaikin Money Flow: 10857249 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.06 - 7.14) Buy
Bollinger Bands (100): (6.19 - 7.59) Buy

RVNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 34.24 Sell
Chaikin Money Flow: -1896957 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.68 - 5.58) Sell
Bollinger Bands (100): (3.88 - 6.26) Sell

RXRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.14 Buy
20-day SMA: 6.59 Buy
50-day SMA: 6.58 Buy
200-day SMA: 8.25 Sell
8-day EMA: 6.36 Buy
20-day EMA: 6.46 Buy
50-day EMA: 6.63 Buy
200-day EMA: 7.62 Sell

RVNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.79 Sell
20-day SMA: 4.37 Sell
50-day SMA: 4.98 Sell
200-day SMA: 4.56 Sell
8-day EMA: 3.85 Sell
20-day EMA: 4.25 Sell
50-day EMA: 4.76 Sell
200-day EMA: 5.92 Sell

Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.

Recursion Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):